Company Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.
It operates through three segments: Lithium, Bromine, and Catalysts.
The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.
It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers.
The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives.
The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets.
Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Country | United States |
IPO Date | Feb 22, 1994 |
Industry | Chemicals - Specialty |
Sector | Basic Materials |
Employees | 9,000 |
CEO | Jerry Kent Masters Jr. |
Contact Details
Address: 4250 Congress Street Charlotte, North Carolina United States | |
Website | https://www.albemarle.com |
Stock Details
Ticker Symbol | ALB |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000915913 |
CUSIP Number | 012653101 |
ISIN Number | US0126531013 |
Employer ID | 54-1692118 |
SIC Code | 2821 |
Key Executives
Name | Position |
---|---|
Jerry Kent Masters Jr. | Chairman, President & Chief Executive Officer |
Donald J. LaBauve Jr. | Chief Accounting Officer, Vice President, Corporate Controller & Chief Financial Officer of Lithium Global Business Unit |
Dr. Glen Merfeld | Chief Technology Officer of Lithium Business |
Neal R. Sheorey | Executive Vice President & Chief Financial Officer |
Netha N. Johnson Jr. | Executive Vice President & Chief Operating Officer |
Brian Tessin | Chief Tax Counsel & Vice President of Tax |
Cynthia Renee Lima | Senior Vice President and Chief External Affairs & Communications Officer |
Eric W. Norris | Executive Vice President & Chief Commercial Officer |
Melissa H. Anderson | Executive Vice President and Chief People & Transformation Officer |
Stacy Grant | Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 06, 2024 | 4 | Filing |
Dec 05, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 20, 2024 | 4 | Filing |
Nov 19, 2024 | 3 | Filing |
Nov 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | 4 | Filing |
Nov 06, 2024 | 10-Q | Quarterly Report |
Nov 06, 2024 | 8-K | Current Report |